Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Pharmacology Study of CS-3150 in Japanese Subjects With Hepatic Impairment
jRCT2080223284Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of esaxerenone in hypertension (HTN) (3 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Pharmacokinetics of esaxerenone: Cmax and Pharmacokinetics of esaxerenone: AUC. Started Aug 2016; status: completed.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT2080223284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223284.